Chinese firm leads A$314mn Vitaco acquisition

10 August 2016 - Deborah Wilkes

Archived

A consortium led by Chinese pharmaceutical company Shanghai Pharma is set to acquire Australian vitamins, minerals and supplements (VMS) specialist Vitaco Holdings in a deal worth A$314 million (US$240 million).

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: